STATE STREET CORP Initiates New Position in Abbott Laboratories (ABT)
STATE STREET CORP, a registered investment adviser, initiated a new position in Abbott Laboratories (NYSE:ABT) during Q2 2026, according to its most recent 13F filing with the…
Read more
